"Ceftriaxone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
Descriptor ID |
D002443
|
MeSH Number(s) |
D02.065.589.099.249.190.190.155 D02.886.665.074.190.190.155 D03.633.100.300.249.190.190.155
|
Concept/Terms |
Ceftriaxone Sodium- Ceftriaxone Sodium
- Sodium, Ceftriaxone
- Ceftriaxone, Disodium Salt, Hemiheptahydrate
- Ceftriaxone, Disodium Salt
Ro13-9904- Ro13-9904
- Ro13 9904
- Ro139904
- Ro-13-9904
- Ro 13-9904
- Ro 13 9904
- Ro 139904
Rocephin- Rocephin
- Rocefalin
- Rocephine
- Rocefin
|
Below are MeSH descriptors whose meaning is more general than "Ceftriaxone".
Below are MeSH descriptors whose meaning is more specific than "Ceftriaxone".
This graph shows the total number of publications written about "Ceftriaxone" by people in this website by year, and whether "Ceftriaxone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2007 | 0 | 2 | 2 |
2012 | 0 | 2 | 2 |
2014 | 1 | 0 | 1 |
2015 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
2017 | 3 | 21 | 24 |
2018 | 8 | 17 | 25 |
2019 | 8 | 7 | 15 |
2020 | 1 | 9 | 10 |
2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Ceftriaxone" by people in Profiles.
-
Multisystem Inflammatory Syndrome in a Pediatric Patient With Sickle Cell Disease and COVID-19: A Case Report. J Pediatr Hematol Oncol. 2022 Jan 01; 44(1):e134-e137.
-
Ischemic Lesions in the Brain of a Neonate With SARS-CoV-2 Infection. Pediatr Infect Dis J. 2021 09 01; 40(9):e340-e343.
-
Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 05 24; 5:CD015043.
-
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ. 2021 05 11; 373:n1038.
-
Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test. Contact Dermatitis. 2021 09; 85(3):366-368.
-
Bacterial meningitis and COVID-19: a complex patient journey. BMJ Case Rep. 2021 Mar 05; 14(3).
-
Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19. Eur J Clin Microbiol Infect Dis. 2021 Jun; 40(6):1353-1355.
-
Austrian syndrome, ceftriaxone-induced agranulocytosis and COVID-19. BMJ Case Rep. 2021 Jan 06; 14(1).
-
First case report of a successfully managed severe COVID-19 infection in Malawi. Malawi Med J. 2020 12; 32(4):226-228.
-
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient. Transpl Infect Dis. 2021 Apr; 23(2):e13501.